Global Cell and Gene Therapy Manufacturing Quality Control Supply, Demand and Key Producers, 2023-2029
The global Cell and Gene Therapy Manufacturing Quality Control market size is expected to reach $ 1325.4 million by 2029, rising at a market growth of 18.2% CAGR during the forecast period (2023-2029).
This report studies the global Cell and Gene Therapy Manufacturing Quality Control demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Manufacturing Quality Control, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Manufacturing Quality Control that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy Manufacturing Quality Control total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Manufacturing Quality Control total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Cell and Gene Therapy Manufacturing Quality Control market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc. and Intertek Group Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Manufacturing Quality Control market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell and Gene Therapy Manufacturing Quality Control Market, By Region:
1. How big is the global Cell and Gene Therapy Manufacturing Quality Control market?
2. What is the demand of the global Cell and Gene Therapy Manufacturing Quality Control market?
3. What is the year over year growth of the global Cell and Gene Therapy Manufacturing Quality Control market?
4. What is the total value of the global Cell and Gene Therapy Manufacturing Quality Control market?
5. Who are the major players in the global Cell and Gene Therapy Manufacturing Quality Control market?
This report studies the global Cell and Gene Therapy Manufacturing Quality Control demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Manufacturing Quality Control, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Manufacturing Quality Control that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy Manufacturing Quality Control total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Manufacturing Quality Control total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Manufacturing Quality Control total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Cell and Gene Therapy Manufacturing Quality Control market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc. and Intertek Group Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Manufacturing Quality Control market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell and Gene Therapy Manufacturing Quality Control Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Sterility Testing
- Purity Testing
- Potency Testing
- Identity Testing
- Others
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations
- Bio-Rad Laboratories,Inc.
- QIAGEN
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Bio-Techne Corporation
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific, Inc.
- Intertek Group Plc
- Eurofins Scientific S.E.
1. How big is the global Cell and Gene Therapy Manufacturing Quality Control market?
2. What is the demand of the global Cell and Gene Therapy Manufacturing Quality Control market?
3. What is the year over year growth of the global Cell and Gene Therapy Manufacturing Quality Control market?
4. What is the total value of the global Cell and Gene Therapy Manufacturing Quality Control market?
5. Who are the major players in the global Cell and Gene Therapy Manufacturing Quality Control market?
1 SUPPLY SUMMARY
1.1 Cell and Gene Therapy Manufacturing Quality Control Introduction
1.2 World Cell and Gene Therapy Manufacturing Quality Control Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy Manufacturing Quality Control Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.3 China Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.4 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.5 Japan Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.6 South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.7 ASEAN Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.8 India Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell and Gene Therapy Manufacturing Quality Control Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region
2.2.1 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2023)
2.2.2 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
3 WORLD CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Manufacturing Quality Control in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Manufacturing Quality Control in 2022
3.3 Cell and Gene Therapy Manufacturing Quality Control Company Evaluation Quadrant
3.4 Cell and Gene Therapy Manufacturing Quality Control Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Manufacturing Quality Control Market: Region Footprint
3.4.2 Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy Manufacturing Quality Control Companies and Market Share, 2018-2023
4.3.1 United States Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue and Market Share, 2018-2023
4.4.1 China Based Cell and Gene Therapy Manufacturing Quality Control Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy Manufacturing Quality Control Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Sterility Testing
5.2.2 Purity Testing
5.2.3 Potency Testing
5.2.4 Identity Testing
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
5.3.2 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2029)
5.3.3 World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Contract Manufacturing Organizations
6.3 Market Segment by Application
6.3.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
6.3.2 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2029)
6.3.3 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bio-Rad Laboratories,Inc.
7.1.1 Bio-Rad Laboratories,Inc. Details
7.1.2 Bio-Rad Laboratories,Inc. Major Business
7.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.1.4 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Bio-Rad Laboratories,Inc. Recent Developments/Updates
7.1.6 Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
7.2 QIAGEN
7.2.1 QIAGEN Details
7.2.2 QIAGEN Major Business
7.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.2.4 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 QIAGEN Recent Developments/Updates
7.2.6 QIAGEN Competitive Strengths & Weaknesses
7.3 Charles River Laboratories International, Inc.
7.3.1 Charles River Laboratories International, Inc. Details
7.3.2 Charles River Laboratories International, Inc. Major Business
7.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.3.4 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Charles River Laboratories International, Inc. Recent Developments/Updates
7.3.6 Charles River Laboratories International, Inc. Competitive Strengths & Weaknesses
7.4 Lonza Group AG
7.4.1 Lonza Group AG Details
7.4.2 Lonza Group AG Major Business
7.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.4.4 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Lonza Group AG Recent Developments/Updates
7.4.6 Lonza Group AG Competitive Strengths & Weaknesses
7.5 Bio-Techne Corporation
7.5.1 Bio-Techne Corporation Details
7.5.2 Bio-Techne Corporation Major Business
7.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.5.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bio-Techne Corporation Recent Developments/Updates
7.5.6 Bio-Techne Corporation Competitive Strengths & Weaknesses
7.6 Merck KGaA
7.6.1 Merck KGaA Details
7.6.2 Merck KGaA Major Business
7.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.6.4 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Merck KGaA Recent Developments/Updates
7.6.6 Merck KGaA Competitive Strengths & Weaknesses
7.7 F. Hoffmann-La Roche Ltd
7.7.1 F. Hoffmann-La Roche Ltd Details
7.7.2 F. Hoffmann-La Roche Ltd Major Business
7.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.7.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.7.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Details
7.8.2 Thermo Fisher Scientific, Inc. Major Business
7.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.8.4 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.8.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.9 Intertek Group Plc
7.9.1 Intertek Group Plc Details
7.9.2 Intertek Group Plc Major Business
7.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.9.4 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Intertek Group Plc Recent Developments/Updates
7.9.6 Intertek Group Plc Competitive Strengths & Weaknesses
7.10 Eurofins Scientific S.E.
7.10.1 Eurofins Scientific S.E. Details
7.10.2 Eurofins Scientific S.E. Major Business
7.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.10.4 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eurofins Scientific S.E. Recent Developments/Updates
7.10.6 Eurofins Scientific S.E. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell and Gene Therapy Manufacturing Quality Control Industry Chain
8.2 Cell and Gene Therapy Manufacturing Quality Control Upstream Analysis
8.3 Cell and Gene Therapy Manufacturing Quality Control Midstream Analysis
8.4 Cell and Gene Therapy Manufacturing Quality Control Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell and Gene Therapy Manufacturing Quality Control Introduction
1.2 World Cell and Gene Therapy Manufacturing Quality Control Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy Manufacturing Quality Control Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.3 China Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.4 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.5 Japan Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.6 South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.7 ASEAN Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.3.8 India Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell and Gene Therapy Manufacturing Quality Control Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region
2.2.1 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2023)
2.2.2 World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029)
3 WORLD CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Manufacturing Quality Control in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Manufacturing Quality Control in 2022
3.3 Cell and Gene Therapy Manufacturing Quality Control Company Evaluation Quadrant
3.4 Cell and Gene Therapy Manufacturing Quality Control Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Manufacturing Quality Control Market: Region Footprint
3.4.2 Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy Manufacturing Quality Control Companies and Market Share, 2018-2023
4.3.1 United States Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue and Market Share, 2018-2023
4.4.1 China Based Cell and Gene Therapy Manufacturing Quality Control Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy Manufacturing Quality Control Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Sterility Testing
5.2.2 Purity Testing
5.2.3 Potency Testing
5.2.4 Identity Testing
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
5.3.2 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2029)
5.3.3 World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Contract Manufacturing Organizations
6.3 Market Segment by Application
6.3.1 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
6.3.2 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2029)
6.3.3 World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bio-Rad Laboratories,Inc.
7.1.1 Bio-Rad Laboratories,Inc. Details
7.1.2 Bio-Rad Laboratories,Inc. Major Business
7.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.1.4 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Bio-Rad Laboratories,Inc. Recent Developments/Updates
7.1.6 Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
7.2 QIAGEN
7.2.1 QIAGEN Details
7.2.2 QIAGEN Major Business
7.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.2.4 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 QIAGEN Recent Developments/Updates
7.2.6 QIAGEN Competitive Strengths & Weaknesses
7.3 Charles River Laboratories International, Inc.
7.3.1 Charles River Laboratories International, Inc. Details
7.3.2 Charles River Laboratories International, Inc. Major Business
7.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.3.4 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Charles River Laboratories International, Inc. Recent Developments/Updates
7.3.6 Charles River Laboratories International, Inc. Competitive Strengths & Weaknesses
7.4 Lonza Group AG
7.4.1 Lonza Group AG Details
7.4.2 Lonza Group AG Major Business
7.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.4.4 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Lonza Group AG Recent Developments/Updates
7.4.6 Lonza Group AG Competitive Strengths & Weaknesses
7.5 Bio-Techne Corporation
7.5.1 Bio-Techne Corporation Details
7.5.2 Bio-Techne Corporation Major Business
7.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.5.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bio-Techne Corporation Recent Developments/Updates
7.5.6 Bio-Techne Corporation Competitive Strengths & Weaknesses
7.6 Merck KGaA
7.6.1 Merck KGaA Details
7.6.2 Merck KGaA Major Business
7.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.6.4 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Merck KGaA Recent Developments/Updates
7.6.6 Merck KGaA Competitive Strengths & Weaknesses
7.7 F. Hoffmann-La Roche Ltd
7.7.1 F. Hoffmann-La Roche Ltd Details
7.7.2 F. Hoffmann-La Roche Ltd Major Business
7.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.7.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.7.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Details
7.8.2 Thermo Fisher Scientific, Inc. Major Business
7.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.8.4 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.8.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.9 Intertek Group Plc
7.9.1 Intertek Group Plc Details
7.9.2 Intertek Group Plc Major Business
7.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.9.4 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Intertek Group Plc Recent Developments/Updates
7.9.6 Intertek Group Plc Competitive Strengths & Weaknesses
7.10 Eurofins Scientific S.E.
7.10.1 Eurofins Scientific S.E. Details
7.10.2 Eurofins Scientific S.E. Major Business
7.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product and Services
7.10.4 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eurofins Scientific S.E. Recent Developments/Updates
7.10.6 Eurofins Scientific S.E. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell and Gene Therapy Manufacturing Quality Control Industry Chain
8.2 Cell and Gene Therapy Manufacturing Quality Control Upstream Analysis
8.3 Cell and Gene Therapy Manufacturing Quality Control Midstream Analysis
8.4 Cell and Gene Therapy Manufacturing Quality Control Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Manufacturing Quality Control Players in 2022
Table 12. World Cell and Gene Therapy Manufacturing Quality Control Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy Manufacturing Quality Control Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Manufacturing Quality Control Player
Table 15. Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Manufacturing Quality Control Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Manufacturing Quality Control Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Manufacturing Quality Control Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2029) & (USD Million)
Table 35. Bio-Rad Laboratories,Inc. Basic Information, Area Served and Competitors
Table 36. Bio-Rad Laboratories,Inc. Major Business
Table 37. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 38. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Bio-Rad Laboratories,Inc. Recent Developments/Updates
Table 40. Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
Table 41. QIAGEN Basic Information, Area Served and Competitors
Table 42. QIAGEN Major Business
Table 43. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 44. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. QIAGEN Recent Developments/Updates
Table 46. QIAGEN Competitive Strengths & Weaknesses
Table 47. Charles River Laboratories International, Inc. Basic Information, Area Served and Competitors
Table 48. Charles River Laboratories International, Inc. Major Business
Table 49. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 50. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Charles River Laboratories International, Inc. Recent Developments/Updates
Table 52. Charles River Laboratories International, Inc. Competitive Strengths & Weaknesses
Table 53. Lonza Group AG Basic Information, Area Served and Competitors
Table 54. Lonza Group AG Major Business
Table 55. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 56. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Lonza Group AG Recent Developments/Updates
Table 58. Lonza Group AG Competitive Strengths & Weaknesses
Table 59. Bio-Techne Corporation Basic Information, Area Served and Competitors
Table 60. Bio-Techne Corporation Major Business
Table 61. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 62. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bio-Techne Corporation Recent Developments/Updates
Table 64. Bio-Techne Corporation Competitive Strengths & Weaknesses
Table 65. Merck KGaA Basic Information, Area Served and Competitors
Table 66. Merck KGaA Major Business
Table 67. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 68. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Merck KGaA Recent Developments/Updates
Table 70. Merck KGaA Competitive Strengths & Weaknesses
Table 71. F. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
Table 72. F. Hoffmann-La Roche Ltd Major Business
Table 73. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 74. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 76. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific, Inc. Major Business
Table 79. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 80. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 82. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
Table 83. Intertek Group Plc Basic Information, Area Served and Competitors
Table 84. Intertek Group Plc Major Business
Table 85. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 86. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Intertek Group Plc Recent Developments/Updates
Table 88. Eurofins Scientific S.E. Basic Information, Area Served and Competitors
Table 89. Eurofins Scientific S.E. Major Business
Table 90. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 91. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control Upstream (Raw Materials)
Table 93. Cell and Gene Therapy Manufacturing Quality Control Typical Customers
List of Figure
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Picture
Figure 2. World Cell and Gene Therapy Manufacturing Quality Control Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy Manufacturing Quality Control Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy Manufacturing Quality Control Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy Manufacturing Quality Control by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Manufacturing Quality Control Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Manufacturing Quality Control Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type in 2022
Figure 31. Sterility Testing
Figure 32. Purity Testing
Figure 33. Potency Testing
Figure 34. Identity Testing
Figure 35. Others
Figure 36. World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2018-2029)
Figure 37. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application in 2022
Figure 39. Pharmaceutical & Biotechnology Companies
Figure 40. Contract Manufacturing Organizations
Figure 41. Cell and Gene Therapy Manufacturing Quality Control Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Manufacturing Quality Control Players in 2022
Table 12. World Cell and Gene Therapy Manufacturing Quality Control Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy Manufacturing Quality Control Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Manufacturing Quality Control Player
Table 15. Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Manufacturing Quality Control Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Manufacturing Quality Control Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Manufacturing Quality Control Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy Manufacturing Quality Control Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2029) & (USD Million)
Table 35. Bio-Rad Laboratories,Inc. Basic Information, Area Served and Competitors
Table 36. Bio-Rad Laboratories,Inc. Major Business
Table 37. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 38. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Bio-Rad Laboratories,Inc. Recent Developments/Updates
Table 40. Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
Table 41. QIAGEN Basic Information, Area Served and Competitors
Table 42. QIAGEN Major Business
Table 43. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 44. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. QIAGEN Recent Developments/Updates
Table 46. QIAGEN Competitive Strengths & Weaknesses
Table 47. Charles River Laboratories International, Inc. Basic Information, Area Served and Competitors
Table 48. Charles River Laboratories International, Inc. Major Business
Table 49. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 50. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Charles River Laboratories International, Inc. Recent Developments/Updates
Table 52. Charles River Laboratories International, Inc. Competitive Strengths & Weaknesses
Table 53. Lonza Group AG Basic Information, Area Served and Competitors
Table 54. Lonza Group AG Major Business
Table 55. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 56. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Lonza Group AG Recent Developments/Updates
Table 58. Lonza Group AG Competitive Strengths & Weaknesses
Table 59. Bio-Techne Corporation Basic Information, Area Served and Competitors
Table 60. Bio-Techne Corporation Major Business
Table 61. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 62. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bio-Techne Corporation Recent Developments/Updates
Table 64. Bio-Techne Corporation Competitive Strengths & Weaknesses
Table 65. Merck KGaA Basic Information, Area Served and Competitors
Table 66. Merck KGaA Major Business
Table 67. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 68. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Merck KGaA Recent Developments/Updates
Table 70. Merck KGaA Competitive Strengths & Weaknesses
Table 71. F. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
Table 72. F. Hoffmann-La Roche Ltd Major Business
Table 73. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 74. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 76. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific, Inc. Major Business
Table 79. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 80. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 82. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
Table 83. Intertek Group Plc Basic Information, Area Served and Competitors
Table 84. Intertek Group Plc Major Business
Table 85. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 86. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Intertek Group Plc Recent Developments/Updates
Table 88. Eurofins Scientific S.E. Basic Information, Area Served and Competitors
Table 89. Eurofins Scientific S.E. Major Business
Table 90. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product and Services
Table 91. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control Upstream (Raw Materials)
Table 93. Cell and Gene Therapy Manufacturing Quality Control Typical Customers
List of Figure
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Picture
Figure 2. World Cell and Gene Therapy Manufacturing Quality Control Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy Manufacturing Quality Control Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Manufacturing Quality Control Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy Manufacturing Quality Control Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy Manufacturing Quality Control by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Manufacturing Quality Control Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Manufacturing Quality Control Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type in 2022
Figure 31. Sterility Testing
Figure 32. Purity Testing
Figure 33. Potency Testing
Figure 34. Identity Testing
Figure 35. Others
Figure 36. World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2018-2029)
Figure 37. World Cell and Gene Therapy Manufacturing Quality Control Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application in 2022
Figure 39. Pharmaceutical & Biotechnology Companies
Figure 40. Contract Manufacturing Organizations
Figure 41. Cell and Gene Therapy Manufacturing Quality Control Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
